Safety and immunogenicity of an investigational adjuvanted hepatitis B vaccine (HB-AS02V) in healthy adults
about
Prophylactic vaccinations in chronic kidney disease: Current statusAn update on safety and immunogenicity of vaccines containing emulsion-based adjuvants.Vaccine Potentiation by Combination AdjuvantsRecent clinical experience with vaccines using MPL- and QS-21-containing adjuvant systems.Hepatitis B vaccination in chronic kidney disease patients: a call for novel vaccines.New adjuvants in evolving vaccine strategies.
P2860
Safety and immunogenicity of an investigational adjuvanted hepatitis B vaccine (HB-AS02V) in healthy adults
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Safety and immunogenicity of a ...... e (HB-AS02V) in healthy adults
@ast
Safety and immunogenicity of a ...... e (HB-AS02V) in healthy adults
@en
type
label
Safety and immunogenicity of a ...... e (HB-AS02V) in healthy adults
@ast
Safety and immunogenicity of a ...... e (HB-AS02V) in healthy adults
@en
prefLabel
Safety and immunogenicity of a ...... e (HB-AS02V) in healthy adults
@ast
Safety and immunogenicity of a ...... e (HB-AS02V) in healthy adults
@en
P2093
P2860
P356
P1433
P1476
Safety and immunogenicity of a ...... e (HB-AS02V) in healthy adults
@en
P2093
Jirí Beran
Lenka Hobzova
Maarten Leyssen
Murielle Surquin
Sherine Kuriyakose
Sophie Houard
Veronika Wertzova
P2860
P304
P356
10.4161/HV.6.7.11883
P577
2010-07-01T00:00:00Z